Literature DB >> 29339101

Atherogenic diet induced lipid accumulation induced NFκB level in heart, liver and brain of Wistar rat and diosgenin as an anti-inflammatory agent.

Ambika Binesh1, Sivasithamparam Niranjali Devaraj2, Devaraj Halagowder3.   

Abstract

Atherogenic Diet (AD) was given to rats to understand the key role of inflammatory mediators in atherosclerotic lesion formation, as a serendipitous study, the diet induced inflammatory mediators in liver and brain, whereas pancreas, kidney and spleen were not affected. The efficacy of diosgenin in ameliorating atherosclerotic progression in heart and suppression of inflammatory mediators in liver and brain of Wistar rat fed on AD diet was investigated. Atherogenic diet triggered inflammatory mediators in heart, liver and brain by upregulating TNF-α, COX-2 and NFkBp65 which are the inflammatory hub, played a key role in pathophysiologic conditions. Endothelial dysfunction, liver tissue with prominent steatosis and the stress evoked in the brain by the atherogenic diet triggered these inflammatory mediators. TNF-α and COX-2 expression was upregulated and its elevation was associated with NFkBp65 activation in heart, liver and brain of atherogenic diet induced rat. Diosgenin downregulated these inflammatory mediators, thereby prevented the atherosclerotic disease progression and concomitant suppression of inflammatory mediators in liver and brain.
Copyright © 2018. Published by Elsevier Inc.

Entities:  

Keywords:  Atherogenic Diet; Brain; Heart; Inflammatory mediators; Liver

Mesh:

Substances:

Year:  2018        PMID: 29339101     DOI: 10.1016/j.lfs.2018.01.012

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  5 in total

1.  Diosgenin-loaded niosome as an effective phytochemical nanocarrier: physicochemical characterization, loading efficiency, and cytotoxicity assay.

Authors:  Mohammad Reza Hajizadeh; Najmeh Parvaz; Mahmood Barani; Alireza Khoshdel; Mohammad Ali Fahmidehkar; Mehdi Mahmoodi; Masoud Torkzadeh-Mahani
Journal:  Daru       Date:  2019-05-27       Impact factor: 3.117

2.  Neuroprotective role of Diosgenin, a NGF stimulator, against Aβ (1-42) induced neurotoxicity in animal model of Alzheimer's disease.

Authors:  Swati Som; Justin Antony; SPalanisamy Dhanabal; Sivasankaran Ponnusankar
Journal:  Metab Brain Dis       Date:  2022-01-13       Impact factor: 3.584

Review 3.  Diosgenin: An Updated Pharmacological Review and Therapeutic Perspectives.

Authors:  Prabhakar Semwal; Sakshi Painuli; Tareq Abu-Izneid; Abdur Rauf; Anshu Sharma; Sevgi Durna Daştan; Manoj Kumar; Mohammed M Alshehri; Yasaman Taheri; Rajib Das; Saikat Mitra; Talha Bin Emran; Javad Sharifi-Rad; Daniela Calina; William C Cho
Journal:  Oxid Med Cell Longev       Date:  2022-05-29       Impact factor: 7.310

Review 4.  Diosgenin and Its Analogs: Potential Protective Agents Against Atherosclerosis.

Authors:  Dan Wang; Xiaolong Wang
Journal:  Drug Des Devel Ther       Date:  2022-07-17       Impact factor: 4.319

5.  Pharmacokinetic Analysis of Diosgenin in Rat Plasma by a UPLC-MS/MS Approach.

Authors:  Pei Liu; Lin Xu; Jing-Han Guo; Jin-Hua Chang; Xi-Gang Liu; He-Fei Xue; Ru-Xing Wang; Zhong-Si Li; Guang-Xin Miao; Cui-Zhe Liu; Jian-Yu Zhou
Journal:  J Anal Methods Chem       Date:  2022-09-30       Impact factor: 2.594

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.